Stay updated on QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page.

Latest updates to the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedOnly minor layout and formatting adjustments were observed on the Study Details page, with core study data such as inclusion criteria, primary outcomes, and enrollment remaining unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check18 days agoNo Change Detected
- Check39 days agoChange DetectedUpdated the page to v3.2.0 and added a government-status notice about operations and funding, replacing the previous v3.1.0 tag.SummaryDifference3%

- Check47 days agoChange Detected- Added: Revision: v3.1.0. - Removed: “Genetic and Rare Diseases Information Center resources: Ovarian cancer” and old revision tag “Revision: v3.0.2.”SummaryDifference0.4%

- Check61 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, indicating a minor patch. The 'Back to Top' element was removed, a minor UI change; there are no changes to pricing, stock, or core content.SummaryDifference0.2%

- Check68 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check75 days agoChange DetectedThe web page has been updated to include a new facility name and location related to ovarian cancer research, along with a new publication reference. The previous version's details about ovarian cancer and niraparib have been significantly reduced.SummaryDifference5%

Stay in the know with updates to QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page.